Telomere science, senolytics, NAD+ protocols, and the clinical evidence behind biological age reversal
"Biological age is no longer a fixed number. It is a variable — and it responds to intervention."— Dr. James Whitfield, Longevity Science Editor
Average biological age reversal with targeted protocols
Stem cell therapy market projected by 2028
Active longevity clinical trials globally
Pioneering research suggests targeted protocols can reverse biological age by an average of 3.2 years. We speak with the scientists leading the charge and examine the clinical evidence.
Dasatinib, quercetin, and the emerging class of senolytic compounds are showing remarkable results in early clinical trials — clearing senescent cells and restoring tissue function.
NMN, NR, and the NAD+ precursor debate — a rigorous review of the clinical evidence, optimal dosing protocols, and what the latest trials actually show.
Beyond the headlines — a data-driven analysis of the lifestyle, dietary, and social factors that genuinely predict exceptional longevity in the world's longest-lived populations.
"We are closer to defeating aging than most people dare to believe. The science has moved from theory to clinical reality in the last five years alone."